A European Medicines Agency committee, on Thursday, accepted the use of an artificial intelligence (AI) tool called AIM-NASH ...

More than 30% of people worldwide have metabolic dysfunction–associated steatotic liver disease (MASLD; formerly nonalcoholic fatty liver disease ... as part of the process. Human editors ...

Fatty pancreas disease, characterized by intra-pancreatic fat deposition, is more prevalent than diabetes, pancreatitis, and ...

Researchers Identify a Gene to Guide Novel Therapeutics of Nonalcoholic Fatty Liver Diseases Mar. 6, 2025 — Investigators have found that the gene Asah1 plays a crucial protective role in ...

A lower prevalence is seen in people with rural backgrounds. In an interview with HT Lifestyle, Dr Rajesh Battina, Consultant - Gastroenterology at Manipal Hospital in Vijayawada, shared, “In ...

The liver is the body’s chemical factory, where most metabolic processes take place. It processes everything you eat and drink, converting them into energy and essential nutrients. Additionally, the ...

Non-alcoholic fatty liver disease (NAFLD ... peer reviewed studies in the translational and clinical human health sciences of liver diseases. JCTH has established high standards for publication ...

Childhood obesity is increasing rapidly, leading to Pediatric Fatty Liver Disease (MAFLD), a condition often underdiagnosed. This disease can progress to severe liver damage and cardiovascular ...

Metabolic dysfunction-associated fatty liver disease (MAFLD) has become a growing global health concern, affecting millions ...

Non-Alcoholic Fatty Liver Disease (NAFLD) Affects 30-40% of U.S. Adults, Driving Significant Market Need for BioHarvest's Future Olive Cell Product Targeting Liver Health Vancouver, British ...